APA (7th ed.) Citation

Dredge, K., Brennan, T. V., Hammond, E., Lickliter, J. D., Lin, L., Bampton, D., . . . Millward, M. (2018). A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours. British journal of cancer, 118(8), 1035-1041. https://doi.org/10.1038/s41416-018-0006-0

Chicago Style (17th ed.) Citation

Dredge, Keith, et al. "A Phase I Study of the Novel Immunomodulatory Agent PG545 (pixatimod) in Subjects with Advanced Solid Tumours." British Journal of Cancer 118, no. 8 (2018): 1035-1041. https://doi.org/10.1038/s41416-018-0006-0.

MLA (9th ed.) Citation

Dredge, Keith, et al. "A Phase I Study of the Novel Immunomodulatory Agent PG545 (pixatimod) in Subjects with Advanced Solid Tumours." British Journal of Cancer, vol. 118, no. 8, 2018, pp. 1035-1041, https://doi.org/10.1038/s41416-018-0006-0.